Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I reached out to Paul last night through LinkedIn about the audit and heard back from him this morning. The language in the emails is very similar. Paul responds if you email him. It’s not rocket science here. The email from Three is totally legit. If you don’t believe just reach out to the guy. This is not mystery theatre here. And glad to hear Paul said nothing has changed from the Q1 target for N&S change. It is obviously in FINRA’s court. It is just a matter of time. In the meantime I add daily.
The price is up nearly 15% today. Perhaps you should adjust expectations.
Thanks for update. Stay tuned. My hunch is that it would be a high priority to open the door to new investors. Good info.
It is just a matter of time. I agree the next catalyst will be the ticker change, projected by company to hit by end of March. When I think back on how quickly Paul got CTYX pink current, I gotta believe they are getting their ducks in a row on the reporting side, particularly with the new management team coming on board. These guys know what they are doing. My guess is that uplist will be to the QB when it happens.
It has been out there for a while and did not stop it from moving from .02 to .21. Don’t think it’s an issue. It will likely come off at some point once they uplist and/or do name change.
Quietly gaining strength. News on progress of entering phase 1 trials should not be far away. Lots of confidence in Baum and Piazza. At right time this will make for a nice acquisition target imo, as company works on developing and gaining FDA approval of cancer drug CycloSam, 40x less toxic than counterpart FDA approved drug Quadramet.
I’ll take this “concerning” investment and 400% gains thus far any day. Wait until the uplist to the QB. Should happen any day now. One person’s negative comments won’t hold back this train.
Added more today at various levels including biggest buy at .165, low of day. Just keeping on with the accumulation.
Calm before the storm.
At this stage of corporate development I would want no one else handling Investor Relations other than Ken Tapp. We hear straight from the horses mouth, and with consistency. And they save on a big salary. Pretty sound IR strategy.
From Investopedia Below. They are just trying to be good compliant soldiers. This is not a red flag at all. Their being compliant is actually a good thing, especially now when the OTC is suspending tickets by the dozens.
What Is a Quiet Period?
Prior to a company’s Initial Public Offering (IPO), the quiet period is an SEC-mandated embargo on promotional publicity. This prohibits management teams or their marketing agents from making forecasts or expressing any opinions about the value of their company.
For publicly-traded stocks, the four weeks before the close of a business quarter is also known as a quiet period. Here again, corporate insiders are forbidden to speak to the public about their business to avoid tipping certain analysts, journalists, investors, and portfolio managers to an unfair advantage – often to avoid the appearance of insider information, whether real or perceived.
They were tweeting all week and the quiet period started last Monday related to providing material information 30 days prior to filing their 10K. I don’t believe the quiet period has anything to do with “shutting down” their Twitter account. They are simply limited in what they can disclose prior to their 10K filing at the end of March. That’s my understanding. If you have other information please share specifics.
Been accumulating every day on what has become a very predictable trading pattern. Buy dips, accumulate and enjoy the ride. She’s about to go.
Ditto on that. Like scooping up some buys on the dips. Can’t help but wonder if the market makers are picking off some stop loss orders as they drive it down.
Also speaks more to the recent increase in internal valuation to $1.9B. This ridiculously low share price will not be around much longer.
It does indeed. Lightbulb went on for me today with those tweets. They want to dominate the digital space in the industries they are entering. And it goes beyond just social media. WOW!
This is a huge series of tweets that speaks to their future plans. Their business model goes far beyond just having a social network within various industries. Industry data will be key differentiator for them. And let’s not forget Ken’s roots are data and technically driven. What we know today only scratches the surface of where they are going.
Good post. Manipulation occurs on every exchange, and is magnified on the OTC. We see these strategies daily on posts. Ken and his team have their act together. Rarely seen a company communicate so transparently, whether on OTC or the big boards.
Don’t think so. Buy any dips. That has been my mantra as I have been adding between .12’s and .16’s.
You just needed to see what the market makers did to it after it ran to .0099 a couple months ago. They took it back to .0013 (87% decline from the high). Buy dips. It will run again, next time to .12-.15. My opinion of course.
I for one have not sold a share. In fact I’ve been adding and have a sizable position, and am excited about what QSAM is doing with improving upon a 23 year old cancer drug with the same doctors involved in the drug’s improvement and evolution. The runway is clear for them to execute and get CycloSam through FDA approval in the appropriate time. There has been very little volume so the sales price is somewhat meaningless until there is more liquidity in the trading. Patience is key as will news updates be by the company on progress. I am pretty confident Chris Nelson is not Oz driving the actual execution of the business plan. My trust is in CEO Baum, Chairman Piazza and the doctors involved in developing the drug, not Nelson.
Not sure. But I like the movement. They probably caught wind of some news that’s coming. It has trades similarly each step up.
Been adding daily. Today at .121 and .126. Splitting hairs at the end of the day after next leg up. We got a good one here. Block out the noise and know what I own. That’s my mantra.
I get it. Any dip hurts. You got to ask yourself what you own here and whether you believe in the company to execute their plan. These penny stock usually trade down in between news cycles, so while it does hurt in looking at the account, consider where the stock was trading a few weeks ago. It is my opinion this will be trading above .50, maybe with a stop along the way in the 20’s/30’s. Not sure how long but it will happen. Dollars May be in their LT future. Based on that, I am using these down days to accumulate. The more shares you own when it takes off the better your profits will be. I have seen two other big moves in this stock in the single penny range. I am confident other big moves will come since the company has progressed very well since these two runs w their drug portfolio and management additions.
With nothing but respect, not true. It peaked at .0556 on 10/16/20, then retraced to a low of .0251 on 12/16, for a 55% reduction. This time it peaked at .2195 on 2/8/21. And today’s low of .131 represents a 40.3% decline from the recent high. The pattern is very similar and not unexpected. I am buying dips. I added 21K more shares today. My average cost is still under $.05 so I am good with adding a few more. It will compound the profits when it next explodes up. Not sure when but it is coming.
Sorry to hear that 3 Flight. Prayers for you and your wife. Hope the fever breaks soon.
WDLF did a smart thing. Yesterday their podcast was thirty minutes. They took the time to only answer questions that had come in from investors. They are doing part two next Monday to give the normal business update. Next week they also start the podcasts for just MJ Link, the first licensee that will IPO. The plan is for them to be listed on the Nasdaq or NYSE when they go public. Pretty smart IR communication strategy. Will keep the shorts on their toes as they will never know when news bombs ?? will drop and/or what information they will share from week to week. They must read very carefully imo.
If we can get .12’s I’ll continue loading the boat. When it is at .50 it will be splitting hairs, even more so when over $1. It’s coming.
Adding here at .16. It won’t be at these levels too long.
Great add to the QSAM board.
“During his tenure at NewLink, Dr. Link led a series of collaborative transactions totaling hundreds of millions of dollars with Merck, Roche and the United States government. He also oversaw the collaboration with Merck to develop EVERBO, the first Ebola vaccine to receive FDA approval.”
Love his FDA approval process and success experiences. Just the type of expertise QSAM needs to take CycloSam through the process to replace the 23 year old drug Quadramet. Obviously time to improve upon an old outdated and harder on the system medication for cancers.
Market Makers such a joke. Had order in at full ask .1698. Did not trigger for a while. Then they just moved the ask you to .17 w no fill. Major game playing here.
10K buy at .1625 was good though. Just keep buying dips.
Nice add. Maybe it was my share count. Either way they ain’t parting with too many shares on the cheap.
Same here I had bid above ask and it did not trigger. Game playing. Only means good things ahead.
I had a buy in on the ask and it did not fill either. I ended up canceling the order. It wasn’t as large as your order but the fact that this is happening on multiple occasions says a lot. The MM’s are manipulating the ask are trying to drive the price down to steal shares cheap imo. I have not felt this good about a position in a long time.
My Ave cost is under .05.
Threelight said it all. I tried to buy on the ask and would not fill either. Any dip, any dip I’m buying and I already have a million and a half shares. I want 2.
It ain’t going under a dime. Mark my words.
I liken the model almost to that of a franchise but it is not technically. Except in this the case the franchisee (called the licensee in their model) will have a company that will go public through the 1A process (likely on the Nasdaq or NYSE according to CEO Ken today) and be publicly traded under its own symbol. WDLF will be like the franchisor who set them up in the business and will own 15% of the company and receive 5% of their revenues for the work they put into setting them up. The licensee will also have a lot of resources at their disposal to help them grow their business and implement best practices to grow their user base and ultimately ad revenues and a platform for e-Commerce, mainly in the form of human capital expertise at Social Life Network and their advisors. It is really a brilliant business model. It is like franchising in the social media world, to allow companies to specialize in a market segment and help move people away from the big social media platforms, which have become too political through censorship. It will give industries that would otherwise be restricted in social media circles because of ideology, a social platform to run their business with fewer restrictions and kick back from the cancel culture that is permeating our society. Brilliant.
Yes it is. Good value un under $1